Delaware Court
Metsera Calls Pfizer’s Threats ‘Nonsense’ as Rift Between Companies Widens
Metsera; Pfizer; Novo Nordisk; merger dispute; litigation; obesity drug acquisition; regulatory approval; Delaware Court of Chancery
Actionable Insights Powered by AI
Metsera; Pfizer; Novo Nordisk; merger dispute; litigation; obesity drug acquisition; regulatory approval; Delaware Court of Chancery